Novavax has made a smaller splash in the U.S. Covid-19 vaccine market than it had hoped. But it's betting on licensing deals ...

Sanofi will take the lead co-commercialization role for ... give this vaccine candidate the highest probability of success ...

Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced ...

As RSV season ramps up, the American Lung Association is partnering with Sanofi to help educate parents and expectant ... infants and some young children at increased risk, and an RSV vaccine received ...

Regarding hospitalizations among immunocompetent older adults, vaccine effectiveness was 83% for the GSK vaccine and 73% for ...

AbbVie is reaching for the Sky(rizi) as it spent a staggering $51.5 million on TV drug ads for its immunology blockbuster in October. | AbbVie is reaching for the Sky(rizi) as it spent a staggering ...

Sanofi has added to its vaccine pipeline with an agreement ... It will highlight vaccines for pneumococcal disease, meningitis, respiratory syncytial virus (RSV), influenza, and chlamydia.

All three RSV vaccines -- GSK's Arexvy, Pfizer's Abrysvo ... Branche reported relationships with Pfizer, Moderna, Merck, ...

Sanofi Korea Corporation (hereinafter referred to as Sanofi) successfully concluded the RSV story contest\ for parents who ...

A Trinity Life Sciences report found that more pharma product launches were successful in 2023 than the year before. Here are ...

A Winnipeg mother with a newborn is pleading with the province to start offering RSV shots to all babies. As we navigate ...